Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Simplexa™ molecular diagnostic test on the 3M™ ...

The world's leading provider of diagnostic testing, Quest Diagnostics Incorporated, announced the CE mark and European launching of the Simplexa Flu A/B & RSV Direct test on the 3M Integrated Cycler.

The world's leading provider of diagnostic testing, Quest Diagnostics Incorporated, reported that its Focus Diagnostics business has CE marked its new Simplexa Cytomegalovirus (CMV) molecular test kit ...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

RT-PCR test is designed to detect and differentiate between four Dengue serotypes in an hour. The Brazilian authorities have cleared Quest Diagnostics’ Simplexa™ Dengue molecular test kit, which was ...

Clostridium difficile infection (CDI) has become the leading cause of healthcare associated infections in the United States and currently accounts for 15% to 20% of infectious diarrhea in the ...